Clinical trial
High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a…
NCT03882021 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT03882021 |
|---|---|
| Title | High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predictor of Recurrence After a Single Ablation Procedure Using a PVI-Only Strategy |
| Official title | High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predictor of Recurrence After a Single Ablation Procedure Using a PVI-Only Strategy |
| Acronym | WAVE-MAP AF |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Cardiac Arrhythmia |
| Intervention type | Procedure |
| Interventions | A specific electrophysiology mapping protocol is applicable with the GRID catheter. |
| Enrollment | 300 |
| Start date | Aug 26, 2019 |
| Primary completion | Nov 30, 2021 |
| Completion | Jan 13, 2022 |
| First posted | Mar 20, 2019 |
| Last update posted | Sep 19, 2024 |
| Countries | Austria, Czechia, France, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: